Folgen
Jaap E. Wieringa
Jaap E. Wieringa
Bestätigte E-Mail-Adresse bei rug.nl - Startseite
Titel
Zitiert von
Zitiert von
Jahr
What about design newness? Investigating the relevance of a neglected dimension of product innovativeness
K Talke, S Salomo, JE Wieringa, A Lutz
Journal of product innovation management 26 (6), 601-615, 2009
2872009
Understanding customer switching behavior in a liberalizing service market: an exploratory study
JE Wieringa, PC Verhoef
Journal of Service Research 10 (2), 174-186, 2007
2282007
Why do firms invest in consumer advertising with limited sales response? A shareholder perspective
EC Osinga, PSH Leeflang, S Srinivasan, JE Wieringa
Journal of Marketing 75 (1), 109-124, 2011
1592011
Generalizations on the effectiveness of pharmaceutical promotional expenditures
STM Kremer, THA Bijmolt, PSH Leeflang, JE Wieringa
International Journal of Research in Marketing 25 (4), 234-246, 2008
1432008
Creating lift versus building the base: current trends in marketing dynamics
PSH Leeflang, THA Bijmolt, J Van Doorn, DM Hanssens, HJ Van Heerde, ...
International Journal of Research in Marketing 26 (1), 13-20, 2009
1182009
The role of marketing in digital business platforms
A Rangaswamy, N Moch, C Felten, G Van Bruggen, JE Wieringa, J Wirtz
Journal of Interactive Marketing 51, 72-90, 2020
1112020
Statistical process control for serially correlated data
JE Wieringa
Labyrint Publication, 1999
1091999
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis
PGM Mol, JE Wieringa, PV NannanPanday, ROB Gans, JE Degener, ...
Journal of Antimicrobial Chemotherapy 55 (4), 550-557, 2005
1022005
Understanding firm, physician and consumer choice behavior in the pharmaceutical industry
P Manchanda, DR Wittink, A Ching, P Cleanthous, M Ding, XJ Dong, ...
Marketing Letters 16 (3), 293-308, 2005
962005
Early marketing matters: A time-varying parameter approach to persistence modeling
EC Osinga, PSH Leeflang, JE Wieringa
Journal of Marketing Research 47 (1), 173-185, 2010
882010
Data analytics in a privacy-concerned world
J Wieringa, PK Kannan, X Ma, T Reutterer, H Risselada, B Skiera
Journal of Business Research 122, 915-925, 2021
692021
Visual outcome, treatment results, and prognostic factors in patients with scleritis
WG Wieringa, JE Wieringa, H Ninette, LI Los
Ophthalmology 120 (2), 379-386, 2013
642013
Modeling markets
P Leeflang, JE Wieringa, THA Bijmolt, KH Pauwels
Springer-Verlag New York, 2016
622016
Competitive reaction-and feedback effects based on VARX models of pooled store data
C Horvath, PSH Leeflang, JE Wieringa, DR Wittink
International Journal of Research in Marketing 22 (4), 415-426, 2005
572005
Modeling the effects of pharmaceutical marketing
PSH Leeflang, JE Wieringa
Marketing Letters 21 (2), 121-133, 2010
522010
No future without the past? Predicting churn in the face of customer privacy
N Holtrop, JE Wieringa, MJ Gijsenberg, PC Verhoef
International Journal of Research in Marketing 34 (1), 154-172, 2017
422017
Advanced methods for modeling markets
PSH Leeflang, JE Wieringa, THA Bijmolt, KH Pauwels
Springer, 2017
342017
When direct health‐care professional communications have an impact on inappropriate and unsafe use of medicines
KC Reber, S Piening, JE Wieringa, SMJM Straus, JM Raine, PA de Graeff, ...
Clinical Pharmacology & Therapeutics 93 (4), 360-365, 2013
342013
Impact of safety‐related regulatory action on drug use in ambulatory care in the Netherlands
S Piening, KC Reber, JE Wieringa, SMJM Straus, PA de Graeff, ...
Clinical Pharmacology & Therapeutics 91 (5), 838-845, 2012
312012
Marketing variables in macro-level diffusion models
E Ruiz-Conde, PSH Leeflang, JE Wieringa
Journal für Betriebswirtschaft 56 (3), 155-183, 2006
252006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20